1. Home
  2. NEPH vs CGBS Comparison

NEPH vs CGBS Comparison

Compare NEPH & CGBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • CGBS
  • Stock Information
  • Founded
  • NEPH 1997
  • CGBS 2018
  • Country
  • NEPH United States
  • CGBS Jersey
  • Employees
  • NEPH N/A
  • CGBS N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • CGBS
  • Sector
  • NEPH Health Care
  • CGBS
  • Exchange
  • NEPH Nasdaq
  • CGBS Nasdaq
  • Market Cap
  • NEPH 36.1M
  • CGBS 30.9M
  • IPO Year
  • NEPH 2004
  • CGBS N/A
  • Fundamental
  • Price
  • NEPH $3.65
  • CGBS $0.01
  • Analyst Decision
  • NEPH Buy
  • CGBS
  • Analyst Count
  • NEPH 1
  • CGBS 0
  • Target Price
  • NEPH $5.00
  • CGBS N/A
  • AVG Volume (30 Days)
  • NEPH 51.5K
  • CGBS 38.0M
  • Earning Date
  • NEPH 08-07-2025
  • CGBS 01-01-0001
  • Dividend Yield
  • NEPH N/A
  • CGBS N/A
  • EPS Growth
  • NEPH N/A
  • CGBS N/A
  • EPS
  • NEPH 0.08
  • CGBS N/A
  • Revenue
  • NEPH $15,517,000.00
  • CGBS N/A
  • Revenue This Year
  • NEPH $17.06
  • CGBS N/A
  • Revenue Next Year
  • NEPH $12.20
  • CGBS N/A
  • P/E Ratio
  • NEPH $49.00
  • CGBS N/A
  • Revenue Growth
  • NEPH 10.34
  • CGBS N/A
  • 52 Week Low
  • NEPH $1.36
  • CGBS $0.04
  • 52 Week High
  • NEPH $5.00
  • CGBS $2.95
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 49.52
  • CGBS N/A
  • Support Level
  • NEPH $3.45
  • CGBS N/A
  • Resistance Level
  • NEPH $3.81
  • CGBS N/A
  • Average True Range (ATR)
  • NEPH 0.26
  • CGBS 0.00
  • MACD
  • NEPH -0.10
  • CGBS 0.00
  • Stochastic Oscillator
  • NEPH 24.37
  • CGBS 0.00

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About CGBS Crown LNG Holdings Limited Ordinary Shares

Crown LNG Holdings Ltd is an LNG infrastructure company that seeks to provide natural gas liquefaction, storage, and re-gasification services. It focuses on enabling a stable and reliable supply of LNG to customers, especially in geographic areas where onshore or floating facilities may be difficult or less desirable as a result of harsh weather conditions, safety or environmental concerns, or cost. It specializes in the design and operation of offshore, all-weather LNG liquefication and re-gasification terminals, such as gravity-based structures. Through Its technologies and design, It believes it can deliver tailored LNG infrastructure suitable for energy-isolated locations, as well as provide critical LNG infrastructure to under-served markets around the world.

Share on Social Networks: